John Zhuang, Ph.D.


Over 20 years of drug development and management experience at big pharmas. Expertise in regulatory affairs, nonclinical safety assessment, and GMP compliance. Substantial people and project management experience.

Former Senior Director of Regulatory Affairs at Johnson & Johnson. Led teams in approval or acquisition of multiple drugs and medical devices. Served as Head of Regulatory Affairs and on Management Board of a subsidiary.

Former Project Leader in Nonclinical Safety Assessment at Eli Lilly and Company. Supported multiple INDs of oncology drugs. Former Senior Scientist at Procter and Gamble Company.

Invited speaker by China FDA at multiple symposiums. Topics included nonclinical safety assessment of new drugs, US 505(2) and OTC regulations, drug-device combination product regulations.

PhD in toxicology from Massachusetts Institute of Technology (MIT). MS in physical chemistry and BS in chemistry from Sun Yat-sen University.